In-house diagnostic devices under the EU IVDR and unwanted side-effects of intentional transparency.
| Autor: | Vanstapel FJLA; Laboratory Medicine, University Hospital Leuven, Leuven, Belgium.; Department of Public Health, Biomedical Sciences Group, Catholic University Leuven, Leuven, Belgium., Boursier G; Department of Molecular Genetics and Cytogenomics, Rare Diseases and Autoinflammatory Unit, CHU Montpellier, Univ Montpellier, Montpellier, France., Cobbaert CM; Department of Clinical Chemistry and Laboratory Medicine, Leiden University Medical Centre, Leiden, The Netherlands. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Clinical chemistry and laboratory medicine [Clin Chem Lab Med] 2023 Jul 27; Vol. 62 (1), pp. e1-e3. Date of Electronic Publication: 2023 Jul 27 (Print Publication: 2024). |
| DOI: | 10.1515/cclm-2023-0750 |
| Databáze: | MEDLINE |
| Externí odkaz: |
|